BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31381534)

  • 1. Pentraxin 3 as a novel diagnostic marker in neonatal sepsis.
    Fahmey SS; Mostafa N
    J Neonatal Perinatal Med; 2019; 12(4):437-442. PubMed ID: 31381534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of novel biomarkers: sTREM-1, pentraxin-3 and pro-adrenomedullin in the early diagnosis of neonatal early onset sepsis.
    Tunç T; Polat A; Özdemir R; Kiliçaslan B; Can E; Çelik HT; Arsan S; Kader Ş; Erol S; Uslu S; Özdemir ÖMA; ; Özcan B; Hanta D; Dilli D; Narter F; Gültekin N; Güzoğlu N; Aydemir Ö
    J Neonatal Perinatal Med; 2020; 13(1):47-54. PubMed ID: 31594258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin 3 concentrations of the mothers with preterm premature rupture of membranes and their neonates, and early neonatal outcome.
    Akin MA; Gunes T; Coban D; Ozgun MT; Akgun H; Kurtoglu S
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1170-5. PubMed ID: 25048752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
    Kim SB; Lee KH; Lee JU; Ann HW; Ahn JY; Jeon YD; Kim JH; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Mar; 58(2):370-379. PubMed ID: 28120568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin-3: A strong novel biochemical marker for appendicitis in children.
    Oztan MO; Aksoy Gokmen A; Ozdemir T; Müderris T; Kaya S; Koyluoglu G
    Am J Emerg Med; 2019 Oct; 37(10):1912-1916. PubMed ID: 30658876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of Pentraxin 3 in diagnosing the severity and cardiovascular function of the children with sepsis].
    Kang X; Zhu Y; Zhang X
    Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):592-8. PubMed ID: 26717657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study.
    Huttunen R; Hurme M; Aittoniemi J; Huhtala H; Vuento R; Laine J; Jylhävä J; Syrjänen J
    PLoS One; 2011 Mar; 6(3):e17653. PubMed ID: 21423699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of pentraxin 3 in a systemic inflammatory response occurring with neonatal bacterial infection.
    Sabry A; Ibrahim M; Khashana A
    J Neonatal Perinatal Med; 2021; 14(4):563-568. PubMed ID: 33523023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Assessment of Pentraxin 3: A Novel Biomarker in Early Detection of Infection in Newborns.
    Baumert M; Surmiak P; Szymkowiak M; Janosz A
    Biomed Res Int; 2021; 2021():6638622. PubMed ID: 34307663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
    Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis.
    Porte R; Davoudian S; Asgari F; Parente R; Mantovani A; Garlanda C; Bottazzi B
    Front Immunol; 2019; 10():794. PubMed ID: 31031772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children.
    Enguix A; Rey C; Concha A; Medina A; Coto D; Diéguez MA
    Intensive Care Med; 2001 Jan; 27(1):211-5. PubMed ID: 11280637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin levels in non-eosinophilic versus eosinophilic asthma.
    Gao P; Tang K; Wang M; Yang Q; Xu Y; Wang J; Zhao J; Xie J
    Clin Exp Allergy; 2018 Aug; 48(8):981-989. PubMed ID: 29754456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis.
    Aydemir C; Aydemir H; Kokturk F; Kulah C; Mungan AG
    BMC Pediatr; 2018 Aug; 18(1):253. PubMed ID: 30068303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
    Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
    Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pentraxin 3 as diagnostic value in classification of patients with heart failure.
    Duran S; Duran I; Kaptanagası FAO; Nartop F; Ciftci H; Korkmaz GG
    Clin Biochem; 2013 Aug; 46(12):983-987. PubMed ID: 23643952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin 3 in neonates with and without diagnosis of pulmonary hypertension.
    Farhadi R; Rafiei A; Hamdamian S; Zamani H; Yazdani J
    Clin Biochem; 2017 Mar; 50(4-5):223-227. PubMed ID: 27838407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary and Serum Interleukin-10, C-Reactive Protein, Mean Platelet Volume, and CRP/MPV Ratio in the Diagnosis of Late-Onset Neonatal Sepsis in Full-Term Neonates.
    Omran A; Sobh H; Abdalla MO; El-Sharkawy S; Rezk AR; Khashana A
    J Immunol Res; 2021; 2021():4884537. PubMed ID: 34676267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.
    Bastrup-Birk S; Skjoedt MO; Munthe-Fog L; Strom JJ; Ma YJ; Garred P
    PLoS One; 2013; 8(9):e73119. PubMed ID: 24039869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
    Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
    Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.